These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8175306)

  • 41. Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents.
    Gregorini L; Fajadet J; Robert G; Cassagneau B; Bernis M; Marco J
    Circulation; 1994 Aug; 90(2):895-907. PubMed ID: 8044961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty.
    Schräder R; Esch I; Ensslen R; Fach WA; Merle H; Scherer D; Sievert H; Spies HF; Zeplin HE
    J Am Coll Cardiol; 1999 Feb; 33(2):395-402. PubMed ID: 9973019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.
    Kip KE; Faxon DP; Detre KM; Yeh W; Kelsey SF; Currier JW
    Circulation; 1996 Oct; 94(8):1818-25. PubMed ID: 8873655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial.
    Serruys PW; Klein W; Tijssen JP; Rutsch W; Heyndrickx GR; Emanuelsson H; Ball SG; Decoster O; Schroeder E; Liberman H
    Circulation; 1993 Oct; 88(4 Pt 1):1588-601. PubMed ID: 8403306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracoronary cyclic-GMP and cyclic-AMP during percutaneous transluminal coronary angioplasty.
    Kremastinos DT; Iliodromitis EK; Markianos M; Apostolou TS; Kyriakides ZS; Karavolias GK
    Int J Cardiol; 1996 Mar; 53(3):227-32. PubMed ID: 8793574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased serum concentrations of adhesion molecules after coronary angioplasty.
    Kurz RW; Graf B; Gremmel F; Wurnig C; Stockenhuber F
    Clin Sci (Lond); 1994 Dec; 87(6):627-33. PubMed ID: 7533067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of neutrophil adhesion molecules expression after coronary angioplasty on the development of restenosis.
    Inoue T; Sakai Y; Fujito T; Hoshi K; Hayashi T; Takayanagi K; Morooka S
    Thromb Haemost; 1998 Jan; 79(1):54-8. PubMed ID: 9459323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Percutaneous transluminal coronary angioplasty catheters versus fluid-filled pressure monitoring guidewires for coronary pressure measurements and correlation with quantitative coronary angiography.
    De Bruyne B; Sys SU; Heyndrickx GR
    Am J Cardiol; 1993 Nov; 72(15):1101-6. PubMed ID: 8237796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for priming and activation of neutrophils early after coronary angioplasty.
    Steg PG; Pasquier C; Huu TP; Chollet-Martin S; Juliard JM; Himbert D; Pocidalo MA; Gourgon R; Hakim J
    Eur J Med; 1993 Jan; 2(1):6-10. PubMed ID: 8258010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coronary balloon angioplasty: a technique that is here to stay.
    Glazier JJ; Piessens J
    Ir Med J; 1991 Mar; 84(1):9-11. PubMed ID: 2045274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology.
    Chronos NA; Goodall AH; Wilson DJ; Sigwart U; Buller NP
    Circulation; 1993 Nov; 88(5 Pt 1):2035-44. PubMed ID: 8222096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes of some immune functions after percutaneous transluminal coronary angioplasty (PTCA).
    Pasqui AL; Di Renzo M; Bova G; Bruni F; Saletti M; Chiarion C; Auteri A
    Int J Clin Pharmacol Res; 1995; 15(4):139-44. PubMed ID: 8871263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early decrease in minimal luminal diameter after successful percutaneous transluminal coronary angioplasty predicts late restenosis.
    Rodriguez A; Santaera O; Larribeau M; Sosa MI; Palacios IF
    Am J Cardiol; 1993 Jun; 71(16):1391-5. PubMed ID: 8517382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A case of aortocoronary dissection as a complication during a percutaneous transluminal coronary angioplasty (PTCA).
    Bae JH; Kim KB; Kim KS; Kim YN
    Int J Cardiol; 1998 Oct; 66(3):237-40. PubMed ID: 9874075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.
    Rensing BJ; Hermans WR; Vos J; Tijssen JG; Rutch W; Danchin N; Heyndrickx GR; Mast EG; Wijns W; Serruys PW
    Circulation; 1993 Sep; 88(3):975-85. PubMed ID: 8353925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of percutaneous transluminal coronary angioplasty on circulating endothelin levels.
    Ameli S; Kaul S; Castro L; Arora C; Mirea A; Shah PK
    Am J Cardiol; 1993 Dec; 72(18):1352-6. PubMed ID: 8256725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and prognostic usefulness of supine bicycle exercise echocardiography in the functional evaluation of patients undergoing elective percutaneous transluminal coronary angioplasty.
    Dagianti A; Rosanio S; Penco M; Dagianti A; Sciomer S; Tocchi M; Agati L; Fedele F
    Circulation; 1997 Mar; 95(5):1176-84. PubMed ID: 9054847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiographic follow-up after successful percutaneous coronary angioplasty for chronic total coronary occlusion: experience in 110 consecutive patients.
    Ishizaka N; Issiki T; Saeki F; Ishizaka Y; Ikari Y; Abe J; Soumitsu Y; Hashimoto H; Masaki K; Yamaguchi T
    Am Heart J; 1994 Jan; 127(1):8-12. PubMed ID: 8273760
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Balloon optimization versus stent study (BOSS): provisional stenting and early recoil after balloon angioplasty.
    Dangas G; Ambrose JA; Rehmann D; Marmur JD; Sharma SK; Hemdal-Monsen C; Sanborn TA; Fischman DL
    Am J Cardiol; 2000 Apr; 85(8):957-61. PubMed ID: 10760334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue factor expression in coronary circulation as a prognostic factor for late restenosis after coronary angioplasty.
    Mizuno O; Ikeda U; Hojo Y; Fujikawa H; Katsuki T; Shimada K
    Cardiology; 2001; 95(2):84-9. PubMed ID: 11423712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.